Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Saba Capital Management, L.P. BMEZ BlackRock Health Sciences Term Trust 13D/A 12.33% 2y
ICAHN CARL C CCK Crown Holdings, Inc. 13D/A 4.99% 2y
Access Industries Holdings LLC GMDA Gamida Cell Ltd. Ordinary Shares 13D/A 1.9% 2y
Rubric Capital Management LP MREO Mereo BioPharma Group plc 13D/A 14.22% 2y
SL Globetrotter, L.P. GB Global Blue Group Holding AG 13D/A 74.4% 2y
ORBIMED ADVISORS LLC APLM Apollomics Inc. 13D/A 10.7% 2y
Cox Investment Holdings, Inc. UP Wheels Up Experience Inc. 13D/A 12.4% 2y
Brian McNulty, Individually and as Trustee of the Bay Shore Trust MIRA Mira Pharmaceuticals, Inc. 13D/A 32.45% 2y
Edward S. Lampert SRG Seritage Growth Properties 13D/A 26.5% 2y
Temasek Holdings (Private) Ltd INTA Intapp, Inc. 13D/A 24.6% 2y
Red Tree GP, LLC CRGX CARGO Therapeutics, Inc. Common Stock 13G 6.4% 2y
Saba Capital Management, L.P. BHV Blackrock Virginia Municipal Bond Trust 13D 5.72% 2y
Saba Capital Management, L.P. NBH Neuberger Municipal Fund Inc. 13D 5.25% 2y
Point72 Asset Management, L.P. CLDX Celldex Therapeutics, Inc. 13G 6.6% 2y
ADAGE CAPITAL PARTNERS GP, L.L.C. AEVA Aeva Technologies, Inc. 13G 6.23% 2y
Phoenix Financial Ltd. ARKO ARKO Corp. 13G 5.34% 2y
BROWN CAPITAL MANAGEMENT LLC PRO Pros Holdings, Inc. 13G/A 4.19% 2y
BAILLIE GIFFORD & CO ILMN Illumina, Inc. 13G/A 5.44% 2y
Rithm Capital Corp. SCU Sculptor Capital Management, Inc. Class A Common Stock 13D/A 100% 2y
Thomas J. Herzfeld Advisors, Inc. DMA Destra Multi-Alternative Fund 13G 10.03% 2y
GENERAL ATLANTIC, L.P. HRT HireRight Holdings Corporation 13D/A 47.5% 2y
FAIRFAX FINANCIAL HOLDINGS LTD/ CAN BB BLACKBERRY Ltd 13D/A 11.8% 2y
PERCEPTIVE ADVISORS LLC NAUT Nautilus Biotechnology, Inc. 13D/A 10.1% 2y
CK Wheels LLC UP Wheels Up Experience Inc. 13D/A 37.1% 2y
PURA VIDA INVESTMENTS, LLC CUTR Cutera, Inc. 13D/A 6.62% 2y
Wengen Alberta, LP LAUR Laureate Education, Inc. 13D/A 12.22% 2y
Howard S. Jonas GNE Genie Energy Ltd. 13D/A 16.6% 2y
WILLIS CHARLES F IV WLFC Willis Lease Finance Corp 13D/A 45.09% 2y
BIOTECHNOLOGY VALUE FUND L P RPTX Repare Therapeutics Inc. Common Shares 13D/A 24.5% 2y
RA CAPITAL MANAGEMENT, L.P. CLYM Climb Bio, Inc. 13D/A 47.7% 2y
Rubric Capital Management LP TXMD TherapeuticsMD, Inc. 13D/A 25.73% 2y
Independence Energy Aggregator L.P. CRGY Crescent Energy Co 13D/A 36.3% 2y
PAG Castle Holdings Pte. Ltd. LX LexinFintech Holdings Ltd. 13D/A 4.9% 2y
CMLS Holdings LLC WGS GeneDx Holdings Corp. 13D/A 13.9% 2y
DELTA AIR LINES, INC. UP Wheels Up Experience Inc. 13D/A 37.8% 2y
Saba Capital Management, L.P. ECAT BlackRock ESG Capital Allocation Term Trust 13D/A 18.89% 2y
Versant Venture Capital VI, L.P. LENZ LENZ Therapeutics, Inc. 13D/A 25.4% 2y
Andrew D. Wingate, Lucinda Falk and Zena Tamler, not individually, but solely as co-trustees of DJPS P.G. Trust. H Hyatt Hotels Corp 13D/A 5.3% 2y
Allied Physicians of California, a Professional Medical Corporation ASTH Astrana Health, Inc. 13D/A 12.9% 2y
Sylebra Capital Ltd PI Impinj Inc 13D/A 14.9% 2y
Great Hill Equity Partners IV, L.P. INTA Intapp, Inc. 13D/A 19.6% 2y
Timothy A. Springer RNAC Cartesian Therapeutics, Inc. 13D/A 27.7% 2y
Timothy Hwang NOTE FiscalNote Holdings, Inc. 13D/A 7.98% 2y
Cannae Holdings, Inc. SST System1, Inc. 13D/A 28.6% 2y
Redmile Group, LLC RGNX REGENXBIO Inc. 13G 9.6% 2y
Hill City Capital, LP ARRY Array Technologies, Inc. 13G 5.14% 2y
Notch View Capital Management, LLC FREE Whole Earth Brands, Inc. Class A Common Stock 13G 5.2% 2y
AH Bio Fund II, L.P. EQRX EQRx, Inc. Common Stock 13D/A 0% 2y
Millennium Management LLC MXCT Maxcyte, Inc. 13G 5.6% 2y
Mork Capital Management, LLC NSFDF NXT Energy Solutions Inc. 13D/A 24.48% 2y